amikacin has been researched along with Bronchial Pneumonia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elman, M; Goldstein, I; Lenaour, G; Marquette, CH; Rouby, JJ; Wallet, F | 1 |
| Ferrari, F; Goldstein, I; Marquette, CH; Nicolas-Robin, A; Rouby, JJ; Wallet, F | 1 |
| Alvarez, A; Baquero, F; Cantón, R; Cobos, N; de Gracia, J; García-Quetglas, E; Gartner, S; Honorato, J; Oliver, A; Salcedo, A | 1 |
| Dubovik, LG; Perederko, LV; Polikarpova, SV; Postnikov, SS; Semykin, SIu | 1 |
| el Desoky, ES; Shoreit, AH | 1 |
| Amirak, ID; Noone, P; Williams, RJ; Wills, MR | 1 |
| Prescott, JF; Sweeney, CR | 1 |
| Lee, CH; Lee, N; Tsai, WC; Wu, JL | 1 |
2 review(s) available for amikacin and Bronchial Pneumonia
| Article | Year |
|---|---|
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bronchopneumonia; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Inhalation; Injections, Intravenous; Lung Diseases; Pneumonia, Bacterial; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2005 |
Treatment of Corynebacterium equi pneumonia of foals: a review.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Bronchopneumonia; Chloramphenicol; Corynebacterium Infections; Drug Combinations; Drug Therapy, Combination; Erythromycin; Horses; Humans; Rifampin; Sulfadiazine; Trimethoprim | 1985 |
2 trial(s) available for amikacin and Bronchial Pneumonia
| Article | Year |
|---|---|
[Clinical and bacteriological efficacy and tolerability of meropenem in the treatment of bronchopulmonary affections in children with mucoviscidosis].
Topics: Amikacin; Anti-Bacterial Agents; Bronchopneumonia; Child; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Thienamycins; Treatment Outcome | 2006 |
Once- versus twice-daily administration of amikacin in pediatric patients with bronchopneumonia: plasma drug concentration and Bayesian pharmacokinetics estimation.
Topics: Amikacin; Anti-Bacterial Agents; Bayes Theorem; Bronchopneumonia; Humans; Infant | 1999 |
4 other study(ies) available for amikacin and Bronchial Pneumonia
| Article | Year |
|---|---|
Influence of lung aeration on pulmonary concentrations of nebulized and intravenous amikacin in ventilated piglets with severe bronchopneumonia.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bronchopneumonia; Injections, Intravenous; Lung; Nebulizers and Vaporizers; Respiration, Artificial; Swine | 2002 |
Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets.
Topics: Administration, Inhalation; Amikacin; Animals; Anti-Bacterial Agents; Bronchopneumonia; Disease Models, Animal; Dose-Response Relationship, Drug; Escherichia coli Infections; Injections, Intravenous; Lung; Nebulizers and Vaporizers; Pneumonia, Bacterial; Respiration, Artificial; Severity of Illness Index; Swine; Treatment Outcome | 2002 |
Amikacin resistance developing in patients with Pseudomonas aeruginosa bronchopneumonia.
Topics: Amikacin; Bronchopneumonia; Drug Resistance, Microbial; Female; Humans; Kanamycin; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections | 1977 |
Pseudomonas pseudomallei infection from drowning: the first reported case in Taiwan.
Topics: Amikacin; Bronchopneumonia; Cephalothin; Drowning; Drug Therapy, Combination; Female; Humans; Melioidosis; Middle Aged; Pseudomonas; Sepsis; Taiwan; Water Microbiology | 1985 |